Calculated prostate specific antigen doubling time subsequent to radical prostatectomy as a predictor of response to salvage pelvic radiotherapy

被引：0
|
作者：
Ward, JF
Zincke, H
Slezak, J
Bergstralh, EJ
Blute, ML
机构：
来源：
JOURNAL OF UROLOGY | 2003年 / 169卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
1079
引用
收藏
页码：278 / 278
页数：1
相关论文
共 50 条
  • [21] Use of pretreatment prostate-specific antigen doubling time to predict outcome after radical prostatectomy
    Egawa, S
    Arai, Y
    Tobisu, K
    Kuwao, S
    Kamoto, T
    Kakehi, Y
    Baba, S
    PROSTATE CANCER AND PROSTATIC DISEASES, 2000, 3 (04) : 269 - 274
  • [22] Use of pretreatment prostate-specific antigen doubling time to predict outcome after radical prostatectomy
    S Egawa
    Y Arai
    K Tobisu
    S Kuwao
    T Kamoto
    Y Kakehi
    S Baba
    Prostate Cancer and Prostatic Diseases, 2000, 3 : 269 - 274
  • [23] Prostate specific antigen doubling time after radical prostatectomy: Effect of neoadjuvant androgen deprivation therapy
    Rabbani, F
    Perrotti, M
    Bastar, A
    Fair, WR
    JOURNAL OF UROLOGY, 1999, 161 (03): : 847 - 852
  • [24] Prostate-specific antigen is a predictor of the efficacy of salvage radiation therapy in patients with recurrent prostate cancer after radical prostatectomy
    Bulychkin, P., V
    Tkachev, S., I
    Matveev, V. B.
    Nazarenko, A., V
    ONKOUROLOGIYA, 2019, 15 (02): : 66 - 72
  • [25] Integrating Prostate-specific Antigen Kinetics into Contemporary Predictive Nomograms of Salvage Radiotherapy After Radical Prostatectomy
    Campbell, Shauna R.
    Tom, Martin C.
    Agrawal, Shree
    Efstathiou, Jason A.
    Michalski, Jeff M.
    Abramowitz, Matthew C.
    Pollack, Alan
    Spratt, Daniel E.
    Hearn, Jason W. D.
    Stephans, Kevin L.
    Gao, Tianming
    Li, Jianbo
    Tendulkar, Rahul D.
    EUROPEAN UROLOGY ONCOLOGY, 2022, 5 (03): : 304 - 313
  • [26] Adjuvant radiotherapy following radical prostatectomy is more effective and less toxic than salvage radiotherapy for a rising prostate specific antigen
    Anscher, MS
    INTERNATIONAL JOURNAL OF CANCER, 2001, 96 (02) : 91 - 93
  • [27] Salvage Radiotherapy for Prostate-specific Antigen Relapse after Radical Prostatectomy for Prostate Cancer: A Single-center Experience
    Yoshida, Takahiro
    Nakayama, Masashi
    Suzuki, Osamu
    Matsuzaki, Kyosuke
    Kobayashi, Yasuyuki
    Takeda, Ken
    Arai, Yasuyuki
    Kakimoto, Ken-ichi
    Nishiyama, Kinji
    Nishimura, Kazuo
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2011, 41 (08) : 1031 - 1036
  • [28] Prostate-specific antigen doubling times are similar in patients with recurrence after radical prostatectomy or radiotherapy: A novel analysis
    Leibman, BD
    Dillioglugil, O
    Scardino, PT
    Abbas, F
    Rogers, E
    Wolfinger, RD
    Kattan, MW
    JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (06) : 2267 - 2271
  • [29] A prostate-specific antigen doubling time of <6 months is prognostic for metastasis and prostate cancer-specific death for patients receiving salvage radiation therapy post radical prostatectomy
    Jackson, William C.
    Johnson, Skyler B.
    Li, Darren
    Foster, Corey
    Foster, Benjamin
    Song, Yeohan
    Schipper, Matthew
    Shilkrut, Mark
    Sandler, Howard M.
    Morgan, Todd M.
    Palapattu, Ganesh S.
    Hamstra, Daniel A.
    Feng, Felix Y.
    RADIATION ONCOLOGY, 2013, 8
  • [30] A prostate-specific antigen doubling time of <6 months is prognostic for metastasis and prostate cancer-specific death for patients receiving salvage radiation therapy post radical prostatectomy
    William C Jackson
    Skyler B Johnson
    Darren Li
    Corey Foster
    Benjamin Foster
    Yeohan Song
    Matthew Schipper
    Mark Shilkrut
    Howard M Sandler
    Todd M Morgan
    Ganesh S Palapattu
    Daniel A Hamstra
    Felix Y Feng
    Radiation Oncology, 8
12345